title: [An investigation on the chromosomal damage in nurses occupationally exposed to antineoplastic drugs].
abstract: OBJECTIVE
  To evaluate their genotoxic risk in nurses occupationally exposed to antineoplastic drugs with chromosomal aberration test and cytokinesis-block micronucleus (CBMN) test.
  
  
  METHODS
  Sixteen nurses in the exposure group were selected from the oncology department of the same hospital, with an average length of exposure of 5.5 years and daily making 8.25 chemotherapeutic preparations in average. The controls were students from a nursing school. Peripheral blood from both groups was cultured at 37 degrees C for 48 h and 72 h, respectively, and then slides were prepared for conventional chromosomal aberration test and CBMN test. One hundred blood cells in metaphase and 1 000 binuclear lymphocytes in each sample were observed under microscope.
  
  
  RESULTS
  The results showed that the mean chromosomal aberration rate in the exposure group was (6.38 +/- 3.30)%, significantly higher than that in the controls (1.25 +/- 0.93)% (P < 0.01). And, the mean micronucleated cell rate in the exposure group was (15.06 +/- 5.30) per thousand, very significantly higher than that in the controls (4.56 +/- 1.67) per thousand (P < 0.01).
  
  
  CONCLUSIONS
  The investigation indicated that chromosome damage rate in the nurses from oncology department was higher than that in the controls, which may be related to their occupational exposure to antineoplastic drugs.
authors.affiliation: Department of Oncology, The First Affilicated Hospital of Jiaxing Medical College, Jiaxing University, Zhejiang 314000, China.
authors.forename: Shi-jie
authors.initials: SJ
authors.lastname: Xu
authors.forename: Jian-xin
authors.initials: JX
authors.lastname: Wang
authors.forename: Dong-ping
authors.initials: DP
authors.lastname: Yang
mesh_terms: D000328:Adult; D000970:Antineoplastic Agents / Q000009:adverse effects*; D002869:Chromosome Aberrations / Q000139:chemically induced*; D005260:Female; D006801:Humans; D015162:Micronucleus Tests; D009153:Mutagens / Q000009:adverse effects; D009726:Nurses; D016273:Occupational Exposure / Q000009:adverse effects*
chemical_list: D000970:Antineoplastic Agents; D009153:Mutagens